tiprankstipranks
Trending News
More News >
Saibo Co., Ltd. (JP:3123)
:3123
Japanese Market
Advertisement

Saibo Co., Ltd. (3123) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3123

Saibo Co., Ltd.

(3123)

Rating:79Outperform
Price Target:
¥614.00
▲(14.55%Upside)
Saibo Co., Ltd. receives a strong overall score due to its robust financial performance and attractive valuation. The stock's technical indicators suggest bullish momentum, further supporting a positive outlook. The absence of earnings call data and corporate events does not detract from the company's solid fundamentals and market position.

Saibo Co., Ltd. (3123) vs. iShares MSCI Japan ETF (EWJ)

Saibo Co., Ltd. Business Overview & Revenue Model

Company DescriptionSaibo Co., Ltd. (3123) is a prominent player in the biotechnology and pharmaceutical sectors, specializing in the research, development, and manufacturing of innovative healthcare products. The company focuses on biopharmaceuticals, diagnostics, and medical devices, aiming to improve patient outcomes through advanced technology and scientific research. With a commitment to quality and innovation, Saibo Co., Ltd. serves a global market, providing solutions that address various medical needs.
How the Company Makes MoneySaibo Co., Ltd. generates revenue primarily through the sale of its biopharmaceutical products, which include therapeutics and vaccines. The company also earns income from diagnostic tools and medical devices that are utilized in healthcare settings. Additionally, Saibo Co., Ltd. engages in strategic partnerships and collaborations with research institutions and other biotech firms, which often lead to joint ventures and co-development agreements, further enhancing its revenue streams. Licensing agreements for its proprietary technologies and products also contribute significantly to its earnings. The company's focus on innovation and adherence to regulatory standards positions it favorably in the competitive biotech landscape, allowing for sustained revenue growth.

Saibo Co., Ltd. Financial Statement Overview

Summary
Saibo Co., Ltd. has demonstrated consistent revenue growth and strong operational efficiency, reflected in its income statement score. However, the balance sheet and cash flow statements highlight concerns with leverage and inconsistent free cash flow, which could affect financial stability.
Income Statement
76
Positive
Saibo Co., Ltd. has demonstrated consistent revenue growth over the years, with a noticeable recovery in gross profit margin following a dip in the previous year. The net profit margin has shown resilience, reflecting efficient cost management despite fluctuations in EBIT. The company's EBITDA margin remains strong, indicating solid operational performance.
Balance Sheet
70
Positive
The balance sheet shows a moderate debt-to-equity ratio, suggesting a balanced approach to leverage. The return on equity has remained healthy, highlighting effective use of shareholder funds. However, the equity ratio indicates a potential risk with a significant portion of assets financed by liabilities.
Cash Flow
65
Positive
While operating cash flow has been stable, the free cash flow growth rate is inconsistent, influenced by varying capital expenditures. The company maintains a positive operating cash flow to net income ratio, but the high variability in free cash flow suggests potential issues with capital investment strategies.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue10.30B11.42B10.18B8.96B6.73B
Gross Profit2.70B2.64B2.40B1.86B1.96B
EBITDA2.71B2.92B2.61B2.20B1.52B
Net Income859.55M945.72M733.21M499.59M587.76M
Balance Sheet
Total Assets41.95B43.53B41.85B42.90B39.13B
Cash, Cash Equivalents and Short-Term Investments3.95B3.64B2.99B2.59B1.82B
Total Debt12.88B14.00B15.07B16.75B14.80B
Total Liabilities21.82B23.97B23.67B25.41B22.52B
Stockholders Equity17.74B17.20B15.97B15.33B14.51B
Cash Flow
Free Cash Flow1.95B1.94B1.93B-1.06B-10.07B
Operating Cash Flow2.37B2.27B2.30B2.04B2.14B
Investing Cash Flow-627.31M-165.85M-147.64M-2.98B-12.14B
Financing Cash Flow-1.48B-1.37B-1.90B1.74B10.07B

Saibo Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price536.00
Price Trends
50DMA
494.94
Positive
100DMA
481.65
Positive
200DMA
473.18
Positive
Market Momentum
MACD
13.15
Negative
RSI
67.50
Neutral
STOCH
53.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3123, the sentiment is Positive. The current price of 536 is above the 20-day moving average (MA) of 518.55, above the 50-day MA of 494.94, and above the 200-day MA of 473.18, indicating a bullish trend. The MACD of 13.15 indicates Negative momentum. The RSI at 67.50 is Neutral, neither overbought nor oversold. The STOCH value of 53.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3123.

Saibo Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (67)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥6.82B8.08
3.01%-9.85%-8.43%
77
Outperform
¥63.34B14.07
2.28%18.84%113.24%
75
Outperform
¥88.42B10.88
2.94%7.01%11.28%
69
Neutral
¥31.45B10.16
3.35%8.60%93.71%
67
Neutral
¥265.88B13.586.45%2.57%5.21%-11.92%
66
Neutral
¥12.30B13.64
5.04%1.05%5.07%
51
Neutral
¥6.61B
28.89%-2448.94%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3123
Saibo Co., Ltd.
532.00
46.32
9.54%
JP:3104
Fujibo Holdings, Inc.
5,710.00
1,323.07
30.16%
JP:3109
Shikibo Ltd.
993.00
-97.56
-8.95%
JP:3201
Japan Wool Textile Co., Ltd.
1,394.00
108.19
8.41%
JP:3409
Kitanihon Spinning Co., Ltd.
236.00
139.00
143.30%
JP:3580
KOMATSU MATERE Co., Ltd.
740.00
5.90
0.80%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 28, 2025